Reassessment of conservative management for stage T1N0M0 transitional cell carcinoma of the bladder

Journal of Urology

Volumn 155, Issue 6, 1996, Pages 1907-1909

  Zhang, Gang Kevin ^a   Uke, Erol T ^a   Sharer, William C ^a   Borkon, William D ^a   Bernstein, Steven M ^a  

^a PARK NICOLLET CLINIC   (United States)

Author keywords

bladder diseases; bladder neoplasms; carcinoma; transitional cell

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CYSTECTOMY; HUMAN; HUMAN TISSUE; INTRAVESICAL DRUG ADMINISTRATION; METASTASIS; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

EID: 0030002880     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66043-9     Document Type: Article

References (15)

1. Malkowicz, S. B., Nichols, P., Lieskovsky, G., Boyd, S. D., Huffman, J. and Skinner, D. G.: The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS, and P2). J. Urol., 144: 641, 1990.
2. Cookson, M. S. and Sarosdy, M. F.: Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy. J. Urol., 148: 797, 1992.
3. Eure, G. R., Ladaga, L. E. and Schellhammer, P. F.: BCG therapy for stage T1 superficial bladder cancer. J. Urol., part 2, 143: 341A, abstract 611, 1990.
4. Herr, H. W., Wartinger, D. D., Fair, W. R. and Oettgen, H. F.: Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup. J. Urol., 147: 1020, 1992.
5. Herr, H. W.: Progression of stage T1 bladder tumors after intravesical bacillus Calmette-Guerin. J. Urol., 145: 40, 1991.
6. Nadler, R. B., Catalona, W. J., Hudson, M. A. and Ratliff, L. T.: Durability of the tumor-free response for intravesical bacillus Calmette-Guerin therapy. J. Urol., 152: 367, 1994.
7. American Joint Committee on Cancer: Manual for Staging of Cancer, 4th ed. Philadelphia: J. B. Lippincott Co., chapt. 34, pp. 195-200, 1992.
8. Martinez-Piñeiro, J. A., Leon, J. J., Martinez-Piñeiro, L., Jr., Fiter, L., Mosteiro, J. A., Navarro, J., Matres, M. J. G. and Cárcamo, P.: Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer. J. Urol., 143: 502, 1990.
9. Herr, H. W., Laudone, V. P., Badalament, R. A., Oettgen, H. F., Sogani, P. C., Freedman, B. D., Melamed, M. R. and Whitmore, W. F., Jr.: BCG therapy alters the progression of superficial bladder cancer. J. Clin. Oncol., 6: 1450, 1988.
10. Steg, A., Belas, M. and Leleu, C.: Intravesical BCG therapy in patients with superficial bladder cancer. In: Immunotherapy of Urological Tumors. Edited by J. B. deKernion. New York: Churchill Livingstone, vol. 1, chapt. 11, pp. 107-112, 1990.
11. Khanna, O. P., Son, D. L., Mazer, H., Read, J., Nugent, D., Cottone, R., Heeg, M., Rezvan, M., Viek, N., Uhlman, R. and Friedmann, M.: Multicenter study of superficial bladder cancer treated with intravesical bacillus Calmette-Guérin or adriamycin. Urology, 35: 101, 1990.
12. Dal Bo, V., Belmonte, P., Verones, A., Lo Re, G., Miotto, E., Merlo, A., Volpe, R. and Francini, M.: Intravesical BCG instillations in patients with carcinoma in situ and PT1 G3 transitional cell carcinoma of the bladder. Eur. Urol., suppl. 1, 18: 43, abstract 82, 1990.
13. Jakse, G., Loidl, W., Seeber, G. and Hofstädter, F.: Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor? J. Urol., 137: 39, 1987.
14. Stöckle, M., Alken, P., Englemann, U., Jacobi, G. H., Riedmiller, H. and Hohenfellner, R.: Radical cystectomy - often too late? Eur. Urol., 13: 361, 1987.
15. Mohamed, S. R., Mishriki, S. F., Persad, R. A., Abrams, P., Gingell, J. C. and Feneley, R. C. L.: Urological audit: the role for an aggressive approach to high grade superficial bladder tumours. Brit. J. Urol., 70: 156, 1992.